In the comorbid insomnia ( PSQI 6 ) subgroup , PRM treatment resulted in significant and clinically meaningful effects versus the placebo , in mean IADL ( P = 0.032 ) , MMSE score ( +1.5 versus -3 points ) ( P = 0.0177 ) , and sleep efficiency ( P = 0.04 ) .